tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Syndax Pharmaceuticals Inc

SNDX
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
9.630USD
+0.260+2.77%
์‹œ์žฅ ์šด์˜ ์‹œ๊ฐ„ย 11/06, 13:16๏ผˆET๏ผ‰
859.96M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

SNDX ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Syndax Pharmaceuticals Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ
์‹œ๊ฐ€์ด์•ก
859.96M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-3.45
์ฃผ๋‹น์ˆœ์ด์ต
-2.79
์ˆ˜์ต
172.35M
์ˆœ์ด์ต
-318.76M
ROE
-189.53%
ROA
-43.70%
Syndax Pharmaceuticals Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜
์ตœ์‹  ์ถœ์‹œ
Nov 2, 2026
EPS / ์˜ˆ์ƒ
-0.55/-0.49
์ˆ˜์ต / ์˜ˆ์ƒ
83.30M/81.85M

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
์žฌ๋ฌด ์ง€ํ‘œ
EPS
21.46%-0.55
33.34%-0.55
50.89%-0.48
28.06%-0.78
28.82%-0.70
-4.26%-0.83
-15.89%-0.98
-8.89%-1.09
-34.49%-0.98
-24.58%-0.80
-43.46%-0.85
-61.14%-1.00
---0.73
---0.64
---0.59
---0.62
---1.84
----
----
----
์ˆ˜์ต
81.59%83.30M
91.76%72.79M
223.64%64.86M
794.90%68.73M
266.97%45.87M
984.51%37.96M
--20.04M
--7.68M
--12.50M
--3.50M
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
33297.36%126.58M
์ˆœ์ด์ต
18.58%-49.43M
31.29%-49.36M
49.71%-42.67M
27.77%-68.01M
27.83%-60.72M
-5.56%-71.85M
-17.19%-84.85M
-29.94%-94.17M
-64.48%-84.13M
-52.56%-68.06M
-76.04%-72.40M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
-140.74%-39.19M
-71.53%-35.40M
-64.00%-37.57M
-34.07%-37.17M
571.03%96.20M
์ˆœ์ด์ต๋ฅ 
55.16%-59.34%
64.17%-67.82%
84.46%-65.79%
91.93%-98.96%
80.33%-132.36%
90.27%-189.28%
---423.34%
---1226.16%
---673.01%
---1944.66%
----
----
----
----
----
----
----
----
----
----
์ด ์ด์ต๋ฅ 
-12.81%83.20%
-1.07%95.59%
0.37%95.94%
7.64%96.06%
-4.58%95.42%
-3.37%96.63%
--95.58%
--89.24%
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
36.27%84.93%
44.35%83.58%
35.05%72.77%
36.92%64.92%
2210055.32%62.33%
1728301.79%57.90%
1539507.14%53.89%
1320723.12%47.42%
-53.08%0.00%
-46.49%0.00%
-5.41%0.00%
-0.83%0.00%
--0.01%
--0.01%
--0.00%
--0.00%
--0.01%
----
----
----
์ˆ˜์ต
81.59%83.30M
91.76%72.79M
223.64%64.86M
794.90%68.73M
266.97%45.87M
984.51%37.96M
--20.04M
--7.68M
--12.50M
--3.50M
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
33297.36%126.58M
์˜์—… ์ด์ต
27.05%-41.90M
42.33%-39.99M
59.04%-34.20M
35.09%-62.55M
35.89%-57.43M
6.55%-69.35M
-5.03%-83.51M
-23.70%-96.36M
-58.95%-89.58M
-49.39%-74.22M
-72.80%-79.51M
-85.34%-77.91M
-60.37%-56.35M
-31.69%-49.68M
-24.84%-46.02M
-143.90%-42.03M
-75.42%-35.14M
-68.91%-37.72M
-35.69%-36.86M
582.10%95.75M
์ˆœ์ด์ต
18.58%-49.43M
31.29%-49.36M
49.71%-42.67M
27.77%-68.01M
27.83%-60.72M
-5.56%-71.85M
-17.19%-84.85M
-29.94%-94.17M
-64.48%-84.13M
-52.56%-68.06M
-76.04%-72.40M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
-140.74%-39.19M
-71.53%-35.40M
-64.00%-37.57M
-34.07%-37.17M
571.03%96.20M
์œ ๋™์ž์‚ฐ
7.10%567.44M
26.96%675.04M
-14.14%471.18M
-12.43%528.08M
27.73%529.83M
19.19%531.68M
20.90%548.75M
3.82%603.06M
8.88%414.81M
9.04%446.06M
2.81%453.90M
18.60%580.88M
6.53%380.97M
4.28%409.08M
5.11%441.51M
9.23%489.79M
50.11%357.63M
49.41%392.29M
50.59%420.06M
50.03%448.40M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
5.93%120.96M
-11.78%99.68M
-8.86%86.17M
16.00%120.12M
92.31%114.19M
166.03%112.99M
86.11%94.55M
78.24%103.55M
51.57%59.38M
40.78%42.47M
114.18%50.80M
99.88%58.10M
88.31%39.17M
-2.45%30.17M
-22.36%23.72M
40.53%29.07M
-27.55%20.80M
27.31%30.93M
24.35%30.55M
9.60%20.68M
์ด ์ž์‚ฐ
25.53%692.67M
18.03%703.65M
-26.23%472.67M
-26.92%529.71M
29.59%551.79M
24.99%596.15M
17.99%640.71M
18.26%724.82M
6.66%425.81M
10.57%476.95M
18.09%543.03M
23.26%612.88M
10.99%399.22M
6.13%431.34M
8.91%459.83M
10.58%497.24M
50.18%359.69M
54.50%406.44M
50.97%422.22M
49.58%449.66M
๋ถ€์ฑ„ ์ด๊ณ„
62.67%709.85M
56.94%688.55M
1.27%431.05M
6.50%465.08M
634.88%436.36M
929.65%438.73M
732.34%425.65M
644.14%436.69M
48.31%59.38M
36.14%42.61M
110.27%51.14M
97.01%58.68M
85.49%40.04M
-29.66%31.30M
-48.98%24.32M
-27.86%29.79M
-46.70%21.59M
-8.25%44.50M
-7.37%47.67M
-14.74%41.29M
์ž๋ณธ ์ด๊ณ„
-114.88%-17.18M
-90.41%15.10M
-80.65%41.62M
-77.57%64.63M
-68.50%115.43M
-63.76%157.42M
-56.28%215.06M
-48.01%288.12M
2.02%366.43M
8.57%434.34M
12.95%491.89M
18.56%554.20M
6.24%359.19M
10.53%400.04M
16.27%435.50M
14.47%467.45M
69.90%338.10M
68.69%361.94M
64.13%374.55M
61.93%408.37M
์ˆœ์˜์—…์ด์ต
61.36%-27.25M
65.52%-30.27M
47.10%-50.34M
-21.08%-69.49M
-13.18%-70.53M
-22.54%-87.80M
-13.90%-95.16M
-38.79%-57.39M
-39.57%-62.32M
-102.55%-71.64M
-112.98%-83.55M
-80.61%-41.35M
-56.44%-44.65M
12.24%-35.37M
6.45%-39.23M
-122.73%-22.89M
-14.43%-28.54M
-67.63%-40.31M
-85.63%-41.93M
744.29%100.71M
์ˆœํˆฌ์ž
-343.65%-176.47M
-140.38%-16.91M
-59.22%38.39M
130.33%81.58M
-16.60%72.43M
-32.17%41.89M
194.71%94.14M
-1551.15%-268.97M
116.70%86.85M
-16.45%61.75M
-599.12%-99.40M
88.16%-16.29M
689.97%40.08M
247.97%73.91M
143.40%19.91M
-129.55%-137.63M
-125.51%-6.79M
-330.39%-49.95M
127.99%8.18M
6.52%-59.96M
์ˆœ์žฌ๋ฌดํ™œ๋™
-49.20%3.19M
45774.77%252.77M
751.40%7.92M
-98.30%5.92M
102.65%6.28M
-18.49%551.00K
-57.10%930.00K
34.41%347.43M
67.37%3.10M
-48.94%676.00K
-12.37%2.17M
58.09%258.48M
113.69%1.85M
-93.90%1.32M
344.17%2.47M
48.94%163.50M
-893.26%-13.53M
260.80%21.72M
-41.98%557.00K
-20.83%109.78M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Syndax Pharmaceuticals Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 172.35M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 23.68M์ž…๋‹ˆ๋‹ค.

Syndax Pharmaceuticals Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 528.08M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -12.43์ž…๋‹ˆ๋‹ค.

Syndax Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Syndax Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ 529.71M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -26.92์ž…๋‹ˆ๋‹ค.

Syndax Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Syndax Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” 465.08M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 6.50์ž…๋‹ˆ๋‹ค.

Syndax Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Syndax Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ 64.63M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -77.57์ž…๋‹ˆ๋‹ค.

Syndax Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Syndax Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -273.08M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 19.60์ž…๋‹ˆ๋‹ค.

Syndax Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Syndax Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” 290.04M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 231.97์ž…๋‹ˆ๋‹ค.

Syndax Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Syndax Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 13.68M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -96.13์ž…๋‹ˆ๋‹ค.

Syndax Pharmaceuticals Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -3.29์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 11.50์ž…๋‹ˆ๋‹ค.

Syndax Pharmaceuticals Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -285.42M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 10.46์ž…๋‹ˆ๋‹ค.

Syndax Pharmaceuticals Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -165.60์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 87.70์ž…๋‹ˆ๋‹ค.

Syndax Pharmaceuticals Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 95.96์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -0.58์ž…๋‹ˆ๋‹ค.

Syndax Pharmaceuticals Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 64.92์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 36.92์ž…๋‹ˆ๋‹ค.

Syndax Pharmaceuticals Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -161.82์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -113.81์ž…๋‹ˆ๋‹ค.

Syndax Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -45.50์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 4.52์ž…๋‹ˆ๋‹ค.

Syndax Pharmaceuticals Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Syndax Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -273.08M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 19.60์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ